Agilon Health, Inc. Hits New 52-Week High of $93.84

Agilon Health, Inc. has reached a significant milestone by hitting a new 52-week high of USD 93.84 on May 28, 2026. This achievement marks a remarkable performance over the past year, with the stock soaring by 1248.81%, significantly outpacing the S&P 500's growth of 28.45% during the same period. As a small-cap company in the Pharmaceuticals & Biotechnology industry, Agilon Health, Inc. has a market capitalization of USD 247 million. Despite its impressive stock performance, the company remains in a loss-making position, reflected in its negative price-to-earnings ratio and return on equity of -102.82%. The stock's price-to-book ratio stands at 0.81, indicating its valuation relative to its assets. With no dividend yield and a debt-to-equity ratio of -0.90, Agilon Health, Inc. continues to navigate its financial landscape while achieving this notable stock price milestone.